23,847
Views
179
CrossRef citations to date
0
Altmetric
Review

In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery

&
Pages 524-539 | Received 03 Sep 2018, Accepted 04 Dec 2018, Published online: 20 Feb 2019

References

  • Ravichandran R. Nanoparticles in drug delivery: potential green nanobiomedicine applications. Int J Green Nanotechnol Biomed. 2009;1:B108–B130.
  • Jong WHD, Borm PJA. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3:133–149.
  • Mohanraj VJ, Chen Y. Nanoparticles a review. Trop J Pharm Res. 2006;5:561–573.
  • Jawahar N, Meyyanathan SN. Polymeric nanoparticles for drug delivery and targeting: a comprehensive review. Int J Health Allied Sci. 2012;1:217–223.
  • Patel S, Bhirde AA, Rusling JF. Nano delivers big: designing molecular missiles for cancer therapeutics. Pharmaceutics. 2011;3:34–52.
  • Kumar A, Badde S, Kamble R, et al. Development and characterization of liposomal drug delivery system for nimesulide. Int J Pharm Sci. 2010;2:87–89.
  • Malhotra M, Jain NK. Niosomes as drug carriers. Indian Drugs. 1994;31:81–86.
  • Udupa N. Niosomes as drug carriers. In: Jain NK, editor. Controlled and novel drug delivery. 1st ed. New Delhi, India: CBS Publishers and Distributors; 2002.
  • Amoabediny G, Haghiralsadat F, Naderinezhad S, et al. Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: a comprehensive review. Int J Polym Mater Polym Biomater. 2018;67:383–400.
  • Mishra DK, Shandilya R, Mishra PK. Lipid based nanocarriers: a translational perspective. Nanomedicine. 2018;14:2023–2050.
  • Malmsten M, Zauscher S. Colloids and surfaces in biology. Curr Opin Colloid Interface Sci. 2013;18:468–480.
  • Radin S, Falaize S, Lee MH, et al. In vitro bioactivity and degradation behaviour of silica xerogels intended as controlled release materials. Biomaterials. 2002;23:3113–3122.
  • Lai C-Y, Trewyn BG, Jeftinija DM, et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc. 2003;125:4451–4459.
  • Konwar R, Ahmed AB. An overview of preparation, characterization and application. Int Res J Pharm. 2016;4:47–57.
  • Ghosh P, Yang X, Arvizo R, et al. Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles. J Am Chem Soc. 2010;132:2642–2645.
  • Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J Control Rel. 2001;70:353–363.
  • Fan X, Zheng W, Singh DJ. Light scattering and surface plasmons on small spherical particles. Light Sci Appl. 2014;3:e179.
  • Ross DJ, Sigel R. Mie scattering by soft core-shell particles and its applications to ellipsometric light scattering. Phys Rev E Stat Nonlin Soft Matter Phys. 2012;85:056710.
  • Kim TH, Kim M, Park HS, et al. Size-dependent cellular toxicity of silver nanoparticles. J Biomed Mater Res A. 2012;100:1033–1043.
  • Park Y-H, Bae HC, Jang Y, et al. Effect of the size and surface charge of silica nanoparticles on cutaneous toxicity. Mol Cell Toxicol. 2013;9:67–74.
  • Jores K, Mehnert W, Drechsler M, et al. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Rel. 2004;95:217–227.
  • Krpetic Z, Singh I, Su W, et al. Directed assembly of DNA- functionalised gold nanoparticles using pyrol- imidazole polyamides. J Am Chem Soc. 2012;134:8356–8359.
  • Krpetic Z, Davidson AM, Volk M, et al. High-resolution sizing of monolayer-protected gold clusters by differential centrifugal sedimentation. ACS Nano. 2013;7:8881–8890.
  • Filipe V, Hawe A, Jiskoot W. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res. 2010;27:796–810.
  • Gmoshinski IV, Khotimchenko SA, Popov VO, et al. Nanomaterials and nanotechnologies: methods of analysis and control. Russ Chem Rev. 2013;2:48–76.
  • Sapsford KE, Tyner KM, Dair BJ, et al. Analyzing nanomaterial bioconjugates: a review of current and emerging purification and characterization techniques. Anal Chem. 2011;83:4453–4488.
  • Patri A, Dobrovolskaia M, Stern S, et al. Preclinical characterization of engineered nanoparticles intended for cancer therapeutics. In: Amiji M, editor. Nanotechnology for cancer therapy. Boca Raton (FL): CRC Press; 2006. p. 105–138.
  • Wang H, Chu PK. Surface characterization of biomaterials. In: Bandyopadhyay A, Bose S, editors. Characterization of biomaterials. Oxford: Academic Press; 2013. p. 105–174.
  • Williams DB, Carter CB. Transmission electron microscopy. 2nd ed. New York: Springer; 2009.
  • Pal SL, Jana U, Manna PK, et al. Nanoparticle: an overview of preparation and characterization. J Appl Pharm Sci. 2011;01:6228–6234.
  • Brice-Profeta S, Arrio M-A, Tronc E, et al. Magnetic order in γ-Fe2O3nanoparticles: a XMCD study. J Magn Magn Mater. 2005;288:354–365.
  • Wu A, Jia J, Luan S. Amphiphilic PMMA/PEI core–shell nanoparticles as polymeric adsorbents to remove heavy metal pollutants Colloids Surf A Physicochem Eng Asp. 2011;384:180–185.
  • Shi HG, Farber L, Michaels JN, et al. Characterization of crystalline drug nanoparticles using atomic force microscopy and complementary techniques. Pharm Res. 2003;20:479–484.
  • Saupe A, Gordon KC, Rades T. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int J Pharm. 2006;314:56–62.
  • Heike B, Tobias U. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Del Rev. 2007;59:379–402.
  • Rao CNR, Biswas K. Characterization of nanomaterials by physical methods. Annu Rev Anal Chem (Palo Alto Calif). 2009;2:435–462.
  • Govender T, Stolnik S, Garnett MC, et al. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Rel. 1999;57:171–185.
  • Kreuter J. Physicochemical characterization of polyacrylic nanoparticles. Int J Pharm. 1983;1:43–58.
  • Hedley M, Curley J, Urban R. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat Med. 1998;4:365–368.
  • Ren J, Zou M, Gao P, et al. Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration. Eur J Pharm Biopharm. 2013;83:141–148.
  • Cho EJ, Holback H, Liu KC, et al. Nanoparticle characterization: state of the art, challenges, and emerging technologies. Mol Pharm. 2013;10:2093–2110.
  • Bocca C, Caputo O, Cavalli RB, et al. Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles. Int J Pharm. 1998;175:185–193.
  • Zhang W, Liu J, Li S, et al. Preparation and evaluation of stealth Tashinone IIA-loaded solid lipid nanoparticles: influence of Poloxamer 188 coating on phagocytic uptake. J Microencapsul. 2008;25:203–209.
  • Vonarbourg A, Passirani C, Saulnier P, et al. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials. 2006;27:4356–4373.
  • Champion J, Mitragotri S. Role of target geometry in phagocytosis. Proc Natl Acad Sci USA. 2006;103:4930–4934.
  • Longmire MR, Ogawa M, Choyke PL, et al. Biologically optimized nanosized molecules and particles: more than just size. Bioconjugate Chem. 2011;22:993–1000.
  • Geng Y, Dalhaimer, P, Cai, S, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nano. 2007;2:249–255.
  • Arnida J-AMM, Ray A, Peterson CM, et al. Geometry and surface characteristics of gold nanoparticles influence their biodistribution uptake by macrophages. Eur J Pharm Biopharm. 2011;77:417–423.
  • Dobrovolskaia M, Aggarwal P, Hall J, et al. Preclinical studies to understand nanoparticles interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharmaceutics. 2008;5:487–495.
  • Vauthier C, Persson B, Lindner P, et al. Protein adsorption and complement activation for diblock copolymer nanoparticles. Biomaterials. 2011;32:1646–1656.
  • Xu P, Gullotti E, Tong L, et al. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharm. 2009;6:190–201.
  • Brown M, Wittwer C. Flow cytometry: principles and clinical applications in hematology. Clin Chem. 2000;46:1221–1229.
  • Tan Y, Fleck RA, Asokanathan C, et al. Confocal microscopy study of pertussis toxin and toxoids on CHO-cells. Hum Vaccin Immunother. 2013;9:332–338.
  • Anirudhan TS, Sandeep S. Synthesis, characterization, cellular uptake and cytotoxicity of a multifunctional magnetic nanocomposite for the targeted delivery and controlled release of doxorubicin to cancer cells. J Mater Chem. 2012;22:12888–12899.
  • Rejman J, Oberle V, Zuhorn IS, et al. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J. 2004;377:159–169.
  • Soldati T, Schliwa M. Powering membrane traffic in endocytosis and recycling. Nat Rev Mol Cell Biol. 2006;7:897–908.
  • Polo S, Di Fiore PP. Endocytosis conducts the cell signaling orchestra. Orchestra Cell. 2006;124:897–900.
  • Sabharanjak S, Mayor S. Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev. 2004;56:1099–1109.
  • Grant BD, Donaldson JG. Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol. 2009;10:597–608.
  • Ranjan A, Pothayee N, Seleem MN, et al. In vitro trafficking and efficacy of core-shell nanostructures for treating intracellular Salmonella infections. Antimicrob Agents Chemother. 2009;5:3985–3988.
  • Ivanov AI. Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol. 2008;440:15–33.
  • Kim SH, Jeong JH, Chun KW, Et al. Target-specific cellular uptake of PLGA nanoparticles coated with poly (L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir. 2005;21:8852–8857.
  • Wang J, Hu X, Xiang D. Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines. Drug Deliv. 2018;25:1319–1327.
  • Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods. 1988;15:61–69.
  • Pal K, Singh VK, Anis A, et al. Hydrogel-based controlled release formulations: designing considerations, characterization techniques and applications. Polym Plast Technol Eng. 2013;52:1391–1422.